The survey revealed that approximately 80.6% of patients gave full marks to the patient services provided by Zhongxin Health platform.

Zhongxin Health provides rehabilitation knowledge, medication management, medication assistance, out-of-hospital rehabilitation support, and other services to patients with cancer and rare disease patients majorly through WeChat Mini Program and WeChat Public Account channels, helping patients improve treatment effects and quality of life.

Bone marrow cancer is one of the top three blood system malignancies in China. With more treatment options available in recent years, patients' survival rates have improved, and their demands for disease management have increased. The survey was conducted in December 2022, with more than 400 bone marrow cancer patients from 139 cities in China using Zhongxin Health platform participating. Among them, approximately 24.5% of patients were diagnosed within the past one year, while approximately 45.8% of patients had been diagnosed for one to three years.

The survey results indicate that majority of the patients found it useful and were satisfied with the services provided via Zhongxin Health platform. Approximately 75.5% of bone marrow cancer patients improved their understanding of the disease through the services provided by the Zhongxin Health platform, while approximately 59.1% of patients increased their confidence in treatment. The average score for patient service evaluations on a scale of 1 to 5 was 4.69, with approximately 80.6% of patients giving the highest rating, and approximately79.0% of patients willing to recommend the platform to more patients.

Additionally, the survey results reflected that there is still a huge market demand for bone marrow cancer patient services. Approximately 67.8% of patients like to obtain knowledge about drug treatment, transplantation, adverse reaction management and others through the platform, approximately 65.2% of patients hope to learn about medical insurance and policy related information, approximately 51.6% of patients are interested in diet and nutrition guidance, approximately 43.2% of patients like to obtain home care knowledge, approximately 35.5% of patients are interested in exercise guidance, and approximately 22.7% of patients hope to hear about other patients' stories.

Most of the content that patients are interested in can be found on the WeChat Mini-Program of Zhongxin Health. Zhongchao looks forward that Zhongxin Health will further improve patient services based on patient recognition and feedbacks to meet patients' needs. Weiguang Yang, Chairman and Chief Executive Officer of Zhongchao, commented, "we are pleased to see that the services provided by Zhongxin Health have been recognized by the majority of bone marrow cancer patients on the platform. We will continue to improve our services to provide patients with comprehensive and high-quality services and supports."